查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198361

智能隱形眼鏡市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Smart Contact Lenses Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 111 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計在 2022 年至 2027 年的預測期內，智能隱形眼鏡市場的複合年增長率為 9.8%。

由於眼科就診人數減少，COVID-19 對 2020 年智能隱形眼鏡市場增長的影響不利。 例如，根據美國疾病控制與預防中心和美國眼科學會在 2020 年 8 月發布的數據，最初眼科就診人數下降了近 80%。 截至6月中旬，美國的眼科醫生就診人數累計下降了40%。 然而，隨著眼科保健在全球範圍內重新開放，在不久的將來可能會恢復正常增長率。 例如，根據 2020 年 6 月在印度發表的一篇文章“COVID-19 後的遠程會診-建議的臨床眼科指南”，衛生和家庭福利部建議眼科保健機構減少患者對擬議指南的就診次數在 COVID-19 情況下進行安全的眼科護理，包括在美國鼓勵遠程諮詢和遠程諮詢，並允許需要測試、眼科檢查或程序的患者根據預約系統進行呼叫。 同樣，2020 年 3 月，美國眼科學會 (AAO) 發布了臨床實踐指南，建議眼科醫生停止非緊急護理。 預計這些因素將增加患者人群對智能隱形眼鏡的需求，從而導致未來幾年的市場增長。

此外，推動市場增長的主要因素是眼科疾病負擔的加重、老花眼在老齡化人群中的患病率增加、青光眼治療技術的進步激增以及智能接觸的主要市場鏡頭製造，一個例子是關聯方的研發活動活躍起來。

智能隱形眼鏡通過測量眼淚中的葡萄糖水平和監測眼內壓來診斷糖尿病和青光眼。 因此，導致眼睛受損的糖尿病負擔日益增加，預計將推動對智能隱形眼鏡的需求，從而顯著促進市場增長，例如 2021 年 11 月宣布的全球糖尿病視網膜病變患病率和預測。到 2045 年的負擔：系統性Review and Meta-Analysis”，在糖尿病患者中，全球患病率為 22.27%。 27%，威脅視力的 DR (VTDR) 6.17%，臨床顯著的黃斑水腫 4.07%。 此外，根據 2021 年 7 月發表的題為“過去 20 年原發性開角型青光眼的患病率：一項薈萃分析和系統評價”的論文，過去 20 年原發性開角型青光眼（POAG）呈現了最新的全球患病率 根據這項研究的結果，POAG 在 40 歲以上人群中的全球患病率為 2.4%。 此外，根據2022年3月的最新消息，在韓國，由Seikwang Han教授和博士領導的POSTECH研究團隊開發了一種智能隱形眼鏡型可穿戴終端，它可以用LED光照射視網膜，以防止和早期治療糖尿病視網膜病變。 這種智能 LED 隱形眼鏡技術因治療各種眼部疾病而備受關注。

因此，由於上述因素，眼科疾病負擔的增加和智能隱形眼鏡技術的進步預計將在預測期內推動對智能隱形眼鏡的需求。

然而，智能隱形眼鏡的高成本和智能隱形眼鏡的認知度低是製約市場增長的主要因素。

智能隱形眼鏡市場趨勢

在智能隱形眼鏡市場，持續血糖監測細分市場有望佔據較大市場份額

按應用來看，連續血糖監測領域預計將佔據很大的市場份額。 智能隱形眼鏡旨在通過持續測量眼淚中的葡萄糖水平來幫助糖尿病患者。 這些鏡片中嵌入了微型傳感器和無線芯片，以跟蹤糖尿病患者的眼壓等生理因素。 傳感器嵌入兩層軟鏡片中。 外層的小開口允許眼淚流入傳感器，傳感器檢測血糖水平並將數據傳輸到無線設備進行存儲。 通過這種方式，實時監測血糖水平可以幫助制定有關飲食、身體活動和藥物平衡的日常決策。

推動這一細分市場增長的主要因素包括研發活動的增加、眼科領域的技術進步以及糖尿病患者越來越多地採用智能隱形眼鏡。 根據 2021 年 6 月發表的“Current Approaches and Future Perspectives”，最近開發的用於生物醫學目的的智能隱形眼鏡已與持續血糖監測和治療糖尿病視網膜病變的按需靈活藥物聯繫在一起。似乎它兼具兩者交付系統。

研發活動的增加也促進了這一細分市場的增長。 例如，在 2020 年 4 月一篇題為“用於糖尿病診斷和治療的無線智能隱形眼鏡”的文章中，研究人員報導了使用智能隱形眼鏡進行持續血糖監測和糖尿病視網膜病變治療的研究，據說已經開發出來。 根據這項研究，基於生物相容性聚合物的智能隱形眼鏡設備包括超薄和柔性電路，以及實時電化學生物傳感、按需控製藥物輸送、無線電源管理和數據通信。包含微控制器芯片為了 此外，該設備能夠測量通過傳統侵入式血糖測試驗證的淚液葡萄糖水平。 這些研究強調了智能隱形眼鏡在連續血糖監測中的重要性。 因此，更多取得積極成果的研究會導致產品獲得批准，這反過來又有助於該細分市場在未來一段時間內的增長。

因此，由於上述發展，預計該細分市場在預測期內將出現顯著增長。

預計北美將佔據全球市場的最大份額

預計北美將佔據很大的市場份額。 這可以歸因於諸如尋求眼科護理的患者增加、產品營銷意識提高、研發活動增加以及市場參與者在該地區的強大影響力等因素。

例如，根據 BrightFocus 基金會 2021 年 7 月的更新，超過 300 萬美國人患有青光眼，其中 270 萬 40 歲以上的人患有最常見的開角型青光眼。據說他患有角性青光眼。 青光眼也是美國非裔美國人和西班牙裔美國人失明的主要原因。 因此，大量青光眼患者將增加該地區對智能隱形眼鏡的需求，最終將促進市場增長。

此外，知名企業採取的幾項戰略舉措也為市場增長做出了貢獻。 例如，2021 年 1 月，專門將微電子技術嵌入水凝膠設備的公司 InWith 將在 CES 活動 2021 上展示令人驚嘆的智能隱形眼鏡，並將在軟性隱形眼鏡中展示增強現實 (AR)，從而打開一扇新的大門計算機化應用的未來。

因此，由於上述因素，市場預計在預測期內將出現顯著增長。

智能隱形眼鏡市場競爭對手分析

智能隱形眼鏡市場競爭激烈，有多家全球和國際參與者。 主要參與者正在採用各種增長戰略，例如合作夥伴關係、協議、合作、新產品發布、地域擴張、兼併和收購，以增加他們在市場上的影響力。 該市場的主要參與者包括 Sensimed、Mojo Vision、Innovega Inc.、InWith Corporation、強生等市場參與者。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 眼病負擔加重
    • 增加智能隱形眼鏡的研發
  • 市場製約因素
    • 智能隱形眼鏡成本高，認知度低
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：百萬美元）

  • 按類型
    • 剛性透氣性 (RGP)
    • 日戴軟鏡片
    • 長戴鏡片
    • 其他
  • 通過申請
    • 連續血糖監測
    • 連續眼壓測量
  • 最終用戶
    • 醫院
    • 眼科診所
    • 其他最終用戶
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東
    • 南美洲

第6章競爭格局

  • 公司簡介
    • Sensimed
    • Mojo Vision
    • Innovega Inc.
    • InWith Corporation
    • Johnson & Johnson
    • Samsung
    • Sony Group Corporation
    • EP Global Communications Inc（EPGL）
    • International Business Machines（IBM）Corporation
    • Huawei Biomed
    • RaayonNova LLC

第7章 市場機會與今後動向

簡介目錄
Product Code: 90543

The Smart Contact Lenses Market is expected to register a CAGR of 9.8% over the forecast period, 2022-2027.

The impact of COVID-19 on the smart contact lenses market's growth was adverse in 2020 due to fewer eye care consultations. For instance, according to data published in August 2020 by the Centers for Disease Control and Prevention and the American Academy of Ophthalmology, there was a nearly 80% initial decrease in ophthalmology visits. As of mid-June, there was still a 40% cumulative decrease in ophthalmology visits in the United States. However, owing to the recommencement of ophthalmology practices and procedures worldwide, the market may soon prevail with a normal growth rate. For instance, according to the article "Tele-consultations in the wake of COVID-19 - Suggested guidelines for clinical ophthalmology," published in June 2020 in India, the Ministry of Health and Family Welfare proposed guidelines for safe ophthalmology practices in the COVID-19 scenario, such as eye care facilities should ensure that telecounseling and teleconsultation should be encouraged to reduce patient visits and appointment systems can be followed to call patients needing examinations, eye investigations, or procedures. Likewise, in March 2020, the American Academy of Ophthalmology (AAO) released practice guidelines advising ophthalmologists to cease providing any treatment other than urgent and emergent care. Such factors are projected to boost the demand for smart contact lenses among the patient population, thereby leading to market growth over the coming years.

Furthermore, the major factors fuelling the market's growth are the rising burden of eye disorders, the growing prevalence of presbyopia in the geriatric population, the surge in advancements in glaucoma treatment technologies, and the increasing research and development activities by key market players for smart contact lens manufacturing.

Smart contact lenses diagnose diabetes and glaucoma by measuring the glucose level in tears and monitoring intraocular pressure within the eyes. The rising burden of diabetes, leading to eye disorders, is thus expected to drive the demand for smart contact lenses, thereby significantly contributing to the market growth, for instance, as per a November 2021 published article titled, "Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis", among individuals with diabetes, the global prevalence was 22.27% for diabetic retinopathy, 6.17% for vision-threatening DR (VTDR), and 4.07% for clinically significant macular edema. In addition, as per a July 2021 published article titled, "Prevalence of primary open-angle glaucoma in the last 20 years: a meta-analysis and systematic review", the study provided the most updated worldwide prevalence of primary open-angle glaucoma (POAG) for the last 20 years. As per the study results, the overall global prevalence of POAG in the population over 40 years old is 2.4%. Moreover, according to a March 2022 update, in South Korea, a POSTECH research team led by Professor Sei Kwang Hahn and Ph.D. candidate Geon-Hui Lee, in collaboration with Dr. Sangbaie Shin of PHI BIOMED Co., developed a smart contact lens-type wearable device to prevent diabetic retinopathy and treat it in its early stages by irradiating 120 µW far-red/LED light to the retina. This technology for smart LED contact lenses has attracted great attention for various ophthalmologic diseases.

Thus, the abovementioned factors indicate that the growing burden of eye disorders and advancements in smart contact lens technology will drive the demand for smart contact lenses over the forecast period.

However, the high cost of smart contact lenses and lack of awareness about these lenses are the major factors restraining the market's growth.

Smart Contact Lenses Market Trends

Continuous Glucose Monitoring Segment is Expected to Hold a Significant Market Share in the Smart Contact Lenses Market

By application, the continuous glucose monitoring segment is expected to hold a significant share in the market. The smart contact lens aims to help diabetes patients by continuously measuring the glucose level in their tears. Miniaturized sensors and wireless chips are built into these lenses to track physiological factors such as intraocular pressure in people with diabetes. Sensors are embedded in the two layers of soft lenses. A small opening in the outer layer allows tears to flow into the sensor, which detects blood sugar levels and transmits the data to the wireless device for storage. Thus, monitoring glucose levels in real-time aids in making informed daily decisions about balancing food, physical activity, and medicine.

The major factors fuelling the segment's growth are an increase in research and development activities, technological advancements in the field of ophthalmology, and the growing adoption of smart contact lenses among the diabetic population, for instance, as per an article titled "Continuous Non-Invasive Glucose Monitoring via Contact Lenses: Current Approaches and Future Perspectives" published in June 2021, recent advances in the development of smart contact lenses for biomedical purposes combine both continuous glucose monitoring with an on-demand flexible drug delivery system for the treatment of diabetic retinopathy.

In addition, increasing research and development activities contribute to the segment's growth. For instance, as per an April 2020 published article titled "Wireless smart contact lens for diabetic diagnosis and therapy," the researchers developed smart contact lenses for continuous glucose monitoring and treating diabetic retinopathy. As per the study, the smart contact lens device, built on a biocompatible polymer, contains ultrathin, flexible electrical circuits, and a microcontroller chip for real-time electrochemical biosensing, on-demand controlled drug delivery, wireless power management, and data communication. Additionally, the study states that the device could measure tear glucose levels to be validated by conventional invasive blood glucose tests. Such studies highlight the significance of smart contact lenses in continuous glucose monitoring. Thus, more studies with positive outcomes are leading to product approvals, which, in turn, contribute to the segment's growth over the coming period.

Thus, due to the abovementioned developments, the segment is expected to witness significant growth over the forecast period.

North America is Expected to Hold the Largest Share in the Global Market

North America is expected to hold a significant share of the market. It can be attributed to factors such as the increasing number of patient visits seeking eye care treatment, a surge in awareness regarding the commercial availability of products, a rising number of research and development activities, and the strong presence of market players in the region.

For instance, as per a July 2021 update by the BrightFocus Foundation, more than three million Americans are living with glaucoma, 2.7 million of whom aged 40 and older are affected by its most common form, open-angle glaucoma. As per the same source, glaucoma is a leading cause of blindness among African Americans and Hispanics in the United States. Thus, the high number of people suffering from glaucoma will likely increase the demand for smart contact lenses within the region, ultimately contributing to market growth.

Additionally, several strategic initiatives undertaken by prominent players are contributing to the market's growth. For instance, in January 2021, InWith, a corporation that specializes in the embedding of microelectronic technology in hydrogel devices, demonstrated its incredible smart contact lenses at the CES event 2021, opening a new door for the future of computerized applications for augmented reality (AR) in soft contact lenses.

Thus, owing to the abovementioned factors, the market is expected to witness significant growth over the forecast period.

Smart Contact Lenses Market Competitor Analysis

The smart contact lenses market is competitive with several global and international players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are Sensimed, Mojo Vision, Innovega Inc., InWith Corporation, and Johnson & Johnson, among other market players.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Burden of Eye Disorders
    • 4.2.2 Increasing Research and Development for Smart Contact Lenses
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Smart Contact Lenses and Lack of Awareness
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Rigid Gas-Permeable (RGP)
    • 5.1.2 Daily-wear Soft Lenses
    • 5.1.3 Extended-wear Lenses
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Continuous Glucose Monitoring
    • 5.2.2 Continuous Intraocular Pressure Monitoring
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.2 Europe
    • 5.4.3 Asia-Pacific
    • 5.4.4 Middle-East
    • 5.4.5 South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Sensimed
    • 6.1.2 Mojo Vision
    • 6.1.3 Innovega Inc.
    • 6.1.4 InWith Corporation
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Samsung
    • 6.1.7 Sony Group Corporation
    • 6.1.8 EP Global Communications Inc (EPGL)
    • 6.1.9 International Business Machines (IBM) Corporation
    • 6.1.10 Huawei Biomed
    • 6.1.11 RaayonNova LLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS